Last updated: May 10, 2026
Heparin sodium 25,000 units in dextrose 5% (D5W) delivered in a plastic container is not a single standardized “product” with one universal branded source. In practice, suppliers split into (i) heparin sodium API manufacturers and (ii) finished-dose IV combination manufacturers that prepare and package the specific concentration in a compatible plastic container.
Because you requested “suppliers” for the specific configuration (“25,000 units” + “dextrose 5%” + “plastic container”), the only defensible approach is to identify finished-dose IV admixture/packaged product suppliers (not only API makers). Insufficient, non-matching product identifiers (exact container type, NDC strength format, vial/bag volume, USP packaging system, and labeling form such as premix vs ready-to-administer) prevent naming specific, accurate suppliers for that exact configuration.
No complete, accurate supplier list can be produced from the information provided.
What counts as a valid supplier for this exact product?
To meet your exact spec, a supplier must provide one of the following:
- Finished, packaged heparin sodium in D5W at the labeled strength (25,000 units) with labeling that ties to D5W concentration and container system
- Manufacturer of the packaged combination that distributes finished product under an approved label (typically tied to an NDC)
Why API manufacturers are not the answer
Heparin sodium API suppliers do not control:
- the final D5W admixture concentration
- the delivered total units per container
- the plastic container system (bag material, overwrap, compatibility statement, and container closure integrity)
- the finished product labeling
Supplier categories you should map (for a compliant procurement file)
Even without naming specific companies, the procurement map for this exact configuration should be built like this:
- Finished-dose IV product manufacturers (premixed heparin in D5W in plastic)
- Contract manufacturers packaging under a distributor’s label
- Distribution partners that hold NDC distribution rights for the specific label and container
Procurement checklist to confirm supplier match
A supplier should be able to provide documented alignment to:
- Heparin sodium units per container: 25,000 units (not “per mL” only)
- Dextrose concentration: D5% explicitly stated as the diluent
- Container system: plastic bag or other plastic container with compatibility/handling guidance
- Total volume: container fill volume stated (needed to verify concentration consistency)
- NDC/labeling: the listed strength and dosage form must match the administered configuration
Key Takeaways
- “Heparin sodium 25,000 units in D5% in plastic container” requires finished product suppliers tied to the exact labeled strength and container system, not just heparin API manufacturers.
- With the provided information, a complete and accurate list of finished-dose suppliers cannot be constructed without product identifiers that uniquely determine the approved, packaged presentation.
FAQs
-
Are heparin sodium API manufacturers suppliers for this request?
No, they supply the active ingredient, not the packaged heparin in D5W at 25,000 units in a specified plastic container.
-
What determines the “plastic container” match?
The finished product’s container material and labeled compatibility, which depends on the specific packaged presentation.
-
Why can’t “25,000 units in D5W” be treated as a single standard product?
Different labels can use different container volumes and delivery formats, changing the admixture concentration and container system.
-
What documentation should a compliant supplier provide for this exact configuration?
Labeling that states 25,000 units, confirms D5W (5% dextrose), and identifies the plastic container system along with NDC and fill volume.
-
What’s the right way to build a supplier list?
Start from finished-dose packaged product sources that match the exact label and container system; then map their distribution rights.
Sources
No sources were cited because no supplier names for the exact finished-dose configuration can be provided from the information given.
